Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Metachronous Ovarian Metastases Following Resection of the Primary Gastric Cancer

  • Jun, Si-Youl (Department of Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • Park, Jong-Kwon (Haeundae Paik Hospital, Inje University College of Medicine)
  • Received : 2011.08.11
  • Accepted : 2011.10.10
  • Published : 2011.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: We performed this study to evaluate the clinical presentation as well as the proper surgical intervention for ovarian metastasis from gastric cancers and these tumors were identified during postoperative follow-up. This will help establish the optimal strategy for improving the survival of patients with this entity. Materials and Methods: 22 patients (3.2%) with ovarian metastasis were noted when performing a retrospective chart review of (693) females patients who had undergone a resection for gastric cancer between 1981 and 2008. The covariates used for the survival analysis were the patient age at the time of ovarian relapse, the size of the tumor, the initial TNM stage of the gastric cancer, the interval to metastasis and the presence of gross residual disease after treatment for Krukenberg tumor. The cumulative survival curves for the patient groups were calculated with the Kaplan-Meier method and they were compared by means of the Log-Rank test. Results: The average age of the patients was 48.6 years (range: 24 to 78 years) and the average survival time of the 22 patients was 18.8 months (the estimated 3-year survival rate was 15.8%) with a range of 2 to 59 months after the diagnosis of Krukenberg tumor. The survival rate for patients without gross residual disease was longer than that of the patients with gross residual disease (P=0.0003). In contrast, patient age, the size of ovarian tumor, the initial stage of gastric adenocarcinoma, the interval to metastasis and adjuvant chemotherapy were not prognostic indicators for survival after the development of ovarian metastasis. Conclusions: Early diagnosis and complete resection are the only possible hope to improve survival. As the 3-year survival rate after resection of Krukenberg tumor is 15.8%, it seems worthwhile to consider performing tumorectomy as the second cytoreduction.

Keywords

References

  1. Wang J, Shi YK, Wu LY, Wang JW, Yang S, Yang JL, et al. Prognostic factors for ovarian metastases from primary gastric cancer. Int J Gynecol Cancer 2008;18:825-832. https://doi.org/10.1111/j.1525-1438.2007.01078.x
  2. Yada-Hashimoto N, Yamamoto T, Kamiura S, Seino H, Ohira H, Sawai K, et al. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol 2003;89:314-317. https://doi.org/10.1016/S0090-8258(03)00075-1
  3. Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH, Noh SH. Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol 2004;94:477-482. https://doi.org/10.1016/j.ygyno.2004.05.007
  4. Kiyokawa T, Young RH, Scully RE. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 2006;30:277-299.
  5. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours (UICC). 6th ed. New York: Wiley-Liss, 2002:65-68.
  6. Kakushima N, Kamoshida T, Hirai S, Hotta S, Hirayama T, Yamada J, et al. Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor. J Gastroenterol 2003;38:1176-1180. https://doi.org/10.1007/s00535-003-1227-3
  7. Nam SY, Choi IJ, Park KW, Kim CG, Lee JY, Kook MC, et al. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol 2009;21:855-860. https://doi.org/10.1097/MEG.0b013e328318ed42
  8. Novak C, Gray LA. Krukenberg tumor of the ovary: clinical and pathological study of four cases. Surg Gynecol Obstet 1938;66:157-165.
  9. Serov SF, Scully RE, Sobin LH. Histological Typing of Ovarian Tumours. International Histological Classification of Tumours. No 9. Geneva: WHO, 1973:17-54.
  10. Lerwill MF, Young RH. Ovarian metastases of intestinal-type gastric carcinoma: a clinicopathologic study of 4 cases with contrasting features to those of the Krukenberg tumor. Am J Surg Pathol 2006;30:1382-1388. https://doi.org/10.1097/01.pas.0000213256.75316.4a
  11. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-242. https://doi.org/10.1046/j.1365-2168.2000.01360.x
  12. Shin DW, Hyung WJ, Noh SH, Min JS. Risk factors for recurrence after curative surgery for early gastric cancer. J Korean Gastric Cancer Assoc 2001;1:106-112.
  13. Berek JS, Natarajan S. Ovarian and fallopian tube cancer. In: Berek JS, ed. Berek and Novak's Gynecology. 14th ed. Philadelphia: Lippincott Williams and Wilkins, 2007:1457-1547.
  14. McGill F, Ritter DB, Rickard C, Kaleya RN, Wadler S, Greston WM. Management of Krukenberg tumors: an 11-year experience and review of literature. Prim Care Update Ob Gyns 1998;5:157-158.
  15. Kim HK, Heo DS, Bang YJ, Kim NK. Prognostic factors of Krukenberg's tumor. Gynecol Oncol 2001;82:105-109. https://doi.org/10.1006/gyno.2001.6210
  16. Shen-Gunther J, Mannel RS. Ascites as a predictor of ovarian malignancy. Gynecol Oncol 2002;87:77-83. https://doi.org/10.1006/gyno.2002.6800
  17. Mates IN, Iosif C, Banceanu G, Ionescu M, Peltecu G, Dinu D, et al. Features of Krukenberg-type tumors--clinical study and review. Chirurgia (Bucur) 2008;103:23-38.
  18. Koyama T, Mikami Y, Saga T, Tamai K, Togashi K. Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation. Abdom Imaging 2007;32:784-795. https://doi.org/10.1007/s00261-007-9186-4
  19. McGill FM, Ritter DB, Rickard CS, Kaleya RN, Wadler S, Greston WM, et al. Krukenberg tumors: can management be improved? Gynecol Obstet Invest 1999;48:61-65. https://doi.org/10.1159/000010136
  20. Dikken JL, Jansen EP, Cats A, Bakker B, Hartgrink HH, Kranenbarg EM, et al. Impact of extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol 2010;28:2430-2436. https://doi.org/10.1200/JCO.2009.26.9654
  21. Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006;24:2903-2909. https://doi.org/10.1200/JCO.2005.05.0245
  22. Schutt U, Wedell J, Koppen P, Reichmann J. Preventive ovariectomy in colorectal cancer. Chirurg 1993;64:1040-1043.
  23. Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, et al. Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer. Oncology 2004;67:19-26. https://doi.org/10.1159/000080281

Cited by

  1. Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis vol.10, pp.2, 2011, https://doi.org/10.7497/j.issn.2095-3941.2013.02.004
  2. Surgical Treatment for Patients with Krukenberg Tumor of Stomach Origin: Clinical Outcome and Prognostic Factors Analysis vol.8, pp.7, 2011, https://doi.org/10.1371/journal.pone.0068227
  3. Surgical Treatment for Patients with Krukenberg Tumor of Stomach Origin: Clinical Outcome and Prognostic Factors Analysis vol.8, pp.7, 2011, https://doi.org/10.1371/journal.pone.0068227
  4. Isolated ovarian metastasis of gastric cancer: Krukenberg tumor vol.17, pp.6, 2011, https://doi.org/10.5114/wo.2013.37542
  5. The Performance of Contrast-Enhanced FDG PET/CT for the Differential Diagnosis of Unexpected Ovarian Mass Lesions in Patients With Nongynecologic Cancer vol.40, pp.2, 2015, https://doi.org/10.1097/rlu.0000000000000667
  6. Right cryptorchid testicular metastasis from descending colon carcinoma: a case report of “Krukenberg tumor” in male vol.17, pp.1, 2011, https://doi.org/10.4103/1008-682x.142769
  7. Metastatic gastric cancer to the female genital tract vol.5, pp.5, 2011, https://doi.org/10.3892/mco.2016.1035
  8. Treatment strategy and prognostic factors for Krukenberg tumors of gastric origin: report of a 10-year single-center experience from China vol.8, pp.47, 2011, https://doi.org/10.18632/oncotarget.19759
  9. Surgical treatment of gastric carcinoma with ovarian metastases vol.30, pp.4, 2011, https://doi.org/10.1515/cipms-2017-0037
  10. Management Of Synchronous Krukenberg Tumors From Gastric Cancer: a Single-center Experience vol.9, pp.22, 2011, https://doi.org/10.7150/jca.25593
  11. Assessment of Circulating Tumor Cells as a Predictive Biomarker of Histology in Women With Suspected Ovarian Cancer vol.49, pp.2, 2018, https://doi.org/10.1093/labmed/lmx084
  12. Treatments and overall survival in patients with Krukenberg tumor vol.300, pp.1, 2011, https://doi.org/10.1007/s00404-019-05167-z
  13. Effects of metastasectomy and other factors on survival of patients with ovarian metastases from gastric cancer: a systematic review and meta‐analysis vol.120, pp.9, 2011, https://doi.org/10.1002/jcb.28708
  14. Prognostic factors in Krukenberg tumor vol.300, pp.5, 2011, https://doi.org/10.1007/s00404-019-05301-x
  15. Ubenimex Suppresses the Ability of Migration and Invasion in Gastric Cancer Cells by Alleviating the Activity of the CD13/NAB1/MAPK Pathway vol.13, pp.None, 2011, https://doi.org/10.2147/cmar.s300515